| Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models SM Carpanini, M Torvell, RJ Bevan, RAJ Byrne, N Daskoulidou, T Saito, ... Acta Neuropathologica Communications 10 (1), 99, 2022 | 28 | 2022 |
| Activity‐Based Probes for HECT E3 Ubiquitin Ligases R Byrne, T Mund, JDF Licchesi ChemBioChem 18 (14), 1415-1427, 2017 | 20 | 2017 |
| Genetic insights into the impact of complement in Alzheimer’s disease M Torvell, SM Carpanini, N Daskoulidou, RAJ Byrne, R Sims, BP Morgan Genes 12 (12), 1990, 2021 | 17 | 2021 |
| Novel monoclonal antibodies against mouse C1q: characterisation and development of a quantitative ELISA for mouse C1q RAJ Byrne, M Torvell, N Daskoulidou, D Fathalla, E Kokkali, ... Molecular Neurobiology 58 (9), 4323-4336, 2021 | 3 | 2021 |
